Logo image of ALPCV.PA

CERINNOV GROUP SA (ALPCV.PA) Stock Fundamental Analysis

EPA:ALPCV - Euronext Paris - Matif - FR0013178712 - Common Stock - Currency: EUR

0.576  +0.02 (+4.35%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to ALPCV. ALPCV was compared to 104 industry peers in the Machinery industry. ALPCV has a bad profitability rating. Also its financial health evaluation is rather negative. ALPCV has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

ALPCV had negative earnings in the past year.
ALPCV had a positive operating cash flow in the past year.
ALPCV had negative earnings in 4 of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: ALPCV reported negative operating cash flow in multiple years.
ALPCV.PA Yearly Net Income VS EBIT VS OCF VS FCFALPCV.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 1M -1M -2M -3M -4M

1.2 Ratios

ALPCV has a worse Return On Assets (-3.04%) than 74.04% of its industry peers.
With a Return On Equity value of -16.77%, ALPCV is not doing good in the industry: 75.96% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -3.04%
ROE -16.77%
ROIC N/A
ROA(3y)-3.05%
ROA(5y)-7.68%
ROE(3y)-16.18%
ROE(5y)-30.91%
ROIC(3y)N/A
ROIC(5y)N/A
ALPCV.PA Yearly ROA, ROE, ROICALPCV.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50 -50

1.3 Margins

ALPCV's Gross Margin of 59.72% is amongst the best of the industry. ALPCV outperforms 87.50% of its industry peers.
ALPCV's Gross Margin has improved in the last couple of years.
ALPCV does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 59.72%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.87%
GM growth 5Y1.57%
ALPCV.PA Yearly Profit, Operating, Gross MarginsALPCV.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40 -40 60

More info and screens

2

2. Health

2.1 Basic Checks

ALPCV does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ALPCV has about the same amount of shares outstanding.
ALPCV has more shares outstanding than it did 5 years ago.
ALPCV has a better debt/assets ratio than last year.
ALPCV.PA Yearly Shares OutstandingALPCV.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 1M 2M 3M 4M
ALPCV.PA Yearly Total Debt VS Total AssetsALPCV.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M

2.2 Solvency

ALPCV has an Altman-Z score of 0.22. This is a bad value and indicates that ALPCV is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of ALPCV (0.22) is worse than 71.15% of its industry peers.
ALPCV has a debt to FCF ratio of 7.35. This is a slightly negative value and a sign of low solvency as ALPCV would need 7.35 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 7.35, ALPCV is in line with its industry, outperforming 51.92% of the companies in the same industry.
A Debt/Equity ratio of 1.12 is on the high side and indicates that ALPCV has dependencies on debt financing.
ALPCV has a worse Debt to Equity ratio (1.12) than 78.85% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.12
Debt/FCF 7.35
Altman-Z 0.22
ROIC/WACCN/A
WACC6.84%
ALPCV.PA Yearly LT Debt VS Equity VS FCFALPCV.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5M 10M

2.3 Liquidity

A Current Ratio of 1.04 indicates that ALPCV should not have too much problems paying its short term obligations.
ALPCV has a worse Current ratio (1.04) than 80.77% of its industry peers.
ALPCV has a Quick Ratio of 1.04. This is a bad value and indicates that ALPCV is not financially healthy enough and could expect problems in meeting its short term obligations.
ALPCV has a Quick ratio of 0.77. This is in the lower half of the industry: ALPCV underperforms 67.31% of its industry peers.
Industry RankSector Rank
Current Ratio 1.04
Quick Ratio 0.77
ALPCV.PA Yearly Current Assets VS Current LiabilitesALPCV.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M

More info and screens

1

3. Growth

3.1 Past

ALPCV shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -336.40%.
ALPCV shows a decrease in Revenue. In the last year, the revenue decreased by -0.19%.
ALPCV shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -4.26% yearly.
EPS 1Y (TTM)-336.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-708%
Revenue 1Y (TTM)-0.19%
Revenue growth 3Y25.68%
Revenue growth 5Y-4.26%
Sales Q2Q%0.43%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
ALPCV is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.35% yearly.
EPS Next Y226%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year10.51%
Revenue Next 2YN/A
Revenue Next 3Y3.35%
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ALPCV.PA Yearly Revenue VS EstimatesALPCV.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2026 5M 10M 15M
ALPCV.PA Yearly EPS VS EstimatesALPCV.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2026 0 0.2 -0.2 0.4 -0.4 -0.6 -0.8

More info and screens

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALPCV. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 4.44, which indicates a rather cheap valuation of ALPCV.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ALPCV indicates a rather cheap valuation: ALPCV is cheaper than 98.08% of the companies listed in the same industry.
ALPCV is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.10, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 4.44
ALPCV.PA Price Earnings VS Forward Price EarningsALPCV.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ALPCV is valued a bit cheaper than 67.31% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, ALPCV is valued cheaply inside the industry as 98.08% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 3.58
EV/EBITDA 6.22
ALPCV.PA Per share dataALPCV.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2

4.3 Compensation for Growth

ALPCV's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ALPCV does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CERINNOV GROUP SA

EPA:ALPCV (3/7/2025, 7:00:00 PM)

0.576

+0.02 (+4.35%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)05-21 2024-05-21/amc
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap2.85M
Analysts86.67
Price Target2.45 (325.35%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 4.44
P/S 0.2
P/FCF 3.58
P/OCF 1.86
P/B 0.87
P/tB N/A
EV/EBITDA 6.22
EPS(TTM)-0.12
EYN/A
EPS(NY)0.13
Fwd EY22.53%
FCF(TTM)0.16
FCFY27.9%
OCF(TTM)0.31
OCFY53.74%
SpS2.94
BVpS0.67
TBVpS-0.51
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.04%
ROE -16.77%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 59.72%
FCFM 5.46%
ROA(3y)-3.05%
ROA(5y)-7.68%
ROE(3y)-16.18%
ROE(5y)-30.91%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.87%
GM growth 5Y1.57%
F-Score4
Asset Turnover0.8
Health
Industry RankSector Rank
Debt/Equity 1.12
Debt/FCF 7.35
Debt/EBITDA 3.24
Cap/Depr 62.03%
Cap/Sales 5.06%
Interest Coverage N/A
Cash Conversion 134.12%
Profit Quality N/A
Current Ratio 1.04
Quick Ratio 0.77
Altman-Z 0.22
F-Score4
WACC6.84%
ROIC/WACCN/A
Cap/Depr(3y)67.56%
Cap/Depr(5y)80.45%
Cap/Sales(3y)6.27%
Cap/Sales(5y)8.76%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-336.4%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-708%
EPS Next Y226%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-0.19%
Revenue growth 3Y25.68%
Revenue growth 5Y-4.26%
Sales Q2Q%0.43%
Revenue Next Year10.51%
Revenue Next 2YN/A
Revenue Next 3Y3.35%
Revenue Next 5YN/A
EBIT growth 1Y-107.63%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year152.02%
EBIT Next 3Y31.44%
EBIT Next 5YN/A
FCF growth 1Y782.22%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y52.9%
OCF growth 3YN/A
OCF growth 5YN/A